Skip to main content
. 2022 May 25;12:864790. doi: 10.3389/fonc.2022.864790

Table 3.

Treatment Duration and Best Response.

Treatment Course Median (range)
All Diagnoses    N=39
 Cycles to best response 2 (1-11)
 Cycles to progression 4 (1-46)
 Cycles on therapy 4 (1-46)
 Time to death (days) 290 (35-1419)
Bone Sarcomas N=21
 Cycles to best response 2 (1-11)
 Cycles to progression 6 (2-46)
 Cycles on therapy 7 (1-46)
 Time to death (days) 385 (97-845)
Best Response N (%)
All Diagnoses N=39
 Complete Response 1 (2.6%)
 Partial Response 2 (5.1%)
 Stable Disease 20 (51.3%)
 Progressive Disease 16 (41%)
Bone Sarcomas N=21
 Complete Response 1 (4.7%)
 Partial Response 1 (4.7%)
 Stable Disease 14 (66.7%)
 Progressive Disease 5 (23.9%)